Amber Cline
Payments from drug & device makers
Across 300 payments — averaging $15.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$563
- Esperion Therapeutics, Inc.$451
- Novo Nordisk$450
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$447
- AstraZeneca$424
- Novartis$412
- plus $2K from 33 others
What the payments were for
- Food & beverage$4,755100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,769 in reported general payments places this provider in the 90th percentile of 1,507 family providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 52 | $80,834 |
| JardianceEmpagliflozin | 31 | $37,287 |
| Spiriva HandihalerTiotropium Bromide | 16 | $14,225 |
| FarxigaDapagliflozin Propanediol | 24 | $13,707 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $9,175 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $8,469 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $7,189 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 28 | $5,523 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 19 | $5,325 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $3,994 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 91 | $2,926 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,426 |
| Novolog FlexpenInsulin Aspart | 17 | $2,299 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 15 | $2,215 |
| Ventolin HfaAlbuterol Sulfate | 33 | $1,895 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $450 | $80,83452 claims |
| Boehringer IngelheimJardiance | $269 | $37,28731 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Shingrix, Arexvy, Incruse Ellipta | $166 | $32,48684 claims |
| AstraZenecaFarxiga, Symbicort | $424 | $16,13435 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,507 family providers in West Virginia.
Other family in Wayne
- Ashley ComerCharleston$213K
- Dana CruseParkersburg$109K
- Sarah KnightCharleston$99K
- Star RoeBarboursville$55K
- Angela SettleCharleston$51K
- Amber DuncanCross Lanes$44K
- Jennifer FieldsHuntington$32K
- Gina LatheyScott Depot$31K
- Jodi BillerScott Depot$29K
- Misty BareboHuntington$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.